Therapeutic inhibition of carbohydrate-protein interactions in vivo.
about
Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolismHeparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectinsCryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activationH (0) blood group determinant is present on soluble human L-selectin expressed in BHK-cells.Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice.P-selectin deficiency attenuates tumor growth and metastasisEffects of Saccharide Spacing and Chain Extension on Toxin Inhibition by Glycopolypeptides of Well-Defined Architecture.Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acalpha2-3Galbeta1-3GalNAc sequences.Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment.Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.Inhibition of L-selectin-mediated leukocyte rolling by synthetic glycoprotein mimics.Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endotheliumDendrimer-like PEO glycopolymers exhibit anti-inflammatory properties.Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion.
P2860
Q24291882-5398578C-352A-46D7-95E0-A6A272F6AA21Q24552437-24663E09-EE2A-45CC-A92E-C7141859089CQ28146065-EF7CBA16-7897-4D48-8DB0-8BCD804F315CQ30704757-8C90E4C8-6772-4959-B1F8-9DDD6F0B2413Q35212146-037C21B8-D887-45D0-8729-90A171E483D7Q36257237-F815D076-7C32-420D-8D7A-A4D55920C614Q37069504-3D6018C5-7A5C-46B3-BA23-59AB97156704Q38336780-318BBA29-201D-4727-B41D-90D6274B41B7Q39787876-082820FF-FA6A-427B-8001-2AA26A1A845DQ39799215-693D9E98-4FF9-478F-8969-1B4AB33EB14EQ40972025-DD7B7FA8-9E69-47B7-800F-2210C11F085EQ41683514-9DE4D256-F4CF-4EF9-9C9E-C23E993994D1Q42986138-BD0C8163-A015-43E1-A1FA-93D34F621136Q46061839-DEA8DC2B-AC9D-48C4-92E3-3670AEC1D3D0
P2860
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@en
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@nl
type
label
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@en
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@nl
prefLabel
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@en
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@nl
P2860
P356
P1476
Therapeutic inhibition of carbohydrate-protein interactions in vivo.
@en
P2093
P2860
P304
P356
10.1172/JCI119244
P407
P577
1997-03-01T00:00:00Z